Cefoxitin Pregnancy and Breastfeeding Warnings
Cefoxitin is also known as: Mefoxin
Cefoxitin Pregnancy Warnings
There are no reports of adverse side effects due to cefoxitin during human pregnancy. Data from its use immediately prior to abortion reveal that it crosses the placenta. In one case, a woman who was given cefoxitin 1 gram intravenously produced maternal and fetal serum levels of zero and 35.7 mcg per mL 4.25 hours after administration; in another case these levels were 10.5 mcg per mL and zero at 0.9 hours after administration. Data from the use of cefoxitin at term after doses of 1 or 2 gram intravenously or intramuscularly reveal umbilical cord levels up to 22 mcg per mL (11% to 90% of the maternal serum levels).
Cefoxitin has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy. Cefoxitin should only be given during pregnancy when need has been clearly established.
Cefoxitin Breastfeeding Warnings
Cefoxitin is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Cefoxitin is considered compatible with breast-feeding by the American Academy of Pediatrics. The manufacturer recommends that caution be used when administering cefoxitin to nursing women.
Approximately 25 hours after a single, prophylactic dose of cefoxitin 2 to 4 grams intravenously was given to 18 women, only one sample in one patient at 19 hours post-dosing revealed detectable cefoxitin levels in milk (0.9 mcg per mL). This represents a miniscule dose to the nursing infant. Some experts, however, warn of the possibility of modification of neonatal gut flora, unknown direct side effects on the nursing infant, and interference with the interpretation of culture results in the evaluation of a suspected infection.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.